Our results are in line with the reported study that hyperglycemia in STZ treated group is due to the cytotoxic effect of STZ on insulin secreting β-cells of pancreas that are also accompanied with an increase in lipid peroxidation. The gene discussed is INS; the disease is Hyperglycemia.